摘要
目的:研究活脑灵治疗脑血管疾病后遗症的临床疗效及安全性。方法:选用31例确诊为脑血管疾病(包括原发病为脑出血及脑梗塞)后遗症的患者,于活脑灵治疗前后分别观察其神经功能缺损程度、评分改变情况。结果:活脑灵治疗15d后,少数病例有所改善,但神经功能缺损程度总评分变化不显著(P>0.05),而治疗30d后,神经功能缺损程度总评分显著减少(P<0.05)。结论:脑血管疾病后遗症可选用活脑灵治疗。
OBJECTIVE:To evaluate the efficacy and safety of buflomedil in treatment of sequel in cerebrovascular disease.METHODS:To observe the changes in total score of neurological functional damage in 31 patients before and after treated with buflomedil.RESULTS:Changes in total score of neurological functional damage were insignificant after 15 d treatment but it decreased significantly after 30 days treatment with buflomedil.CONCLUSION:The results of this trial suggested that buflomedil maybe a useful agent for treatment of sequel in cerebrovascular disease but the treatment should exceeded 30 days.
出处
《中国新药杂志》
CAS
CSCD
1998年第5期377-379,共3页
Chinese Journal of New Drugs